4/A: CVS Health Executive J. David Joyner Corrects Stock Grant Details in Amended SEC Filing
SEC Filing (Form 4/A)
J. David Joyner, President and CEO of CVS Health, files an amendment to a previous SEC Form 4 to correct the type and number of securities granted, clarifying that he received restricted stock units (RSUs) instead of stock options.
Summary
- J. David Joyner, President and CEO of CVS Health, filed an amended SEC Form 4 on May 9, 2025, to correct information regarding a securities grant.
- The amendment clarifies that on April 1, 2025, Joyner received 53,324 restricted stock units (RSUs) under the company's 2017 Incentive Compensation Plan.
- The original Form 4, filed on April 3, 2025, incorrectly reported the grant as 226,138 stock options.
- The RSUs vest in four equal annual installments, starting on April 1, 2026.
- Following the reported transaction, Joyner beneficially owns 82,515 shares of CVS Health common stock.
Sentiment
Score: 7
Explanation: The document is a routine regulatory filing correcting a previous error. It doesn't contain any information that would significantly impact investor sentiment, but the correction itself is a positive sign of transparency.
Industry Context
This filing is a routine disclosure related to executive compensation and is required by the SEC to ensure transparency in insider transactions. It does not reflect any broader industry trends.
Stakeholder Impact
- The correction of the filing ensures accurate information for shareholders regarding executive compensation.
Key Dates
| Date | Description |
|---|---|
| 04/01/2025 | Date of the RSU grant to J. David Joyner. |
| 04/03/2025 | Date of the original SEC Form 4 filing that incorrectly reported the grant as stock options. |
| 04/01/2026 | Commencement date for the vesting of the RSUs in four equal annual installments. |
| 05/09/2025 | Date of the amended SEC Form 4/A filing. |
Keywords
SEC Form 4, Amendment, Restricted Stock Units, RSUs, CVS Health, J. David Joyner, Beneficial Ownership, Incentive Compensation Plan, Securities Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.